Original Article

Diagnostic value of antibody testing in comparison with lung scan and PCR in patients suspected of having COVID-19

Abstract

Background and Objectives: SARS-CoV-2 is a newly discovered viral infection. It’s still unclear how antibodies react in infected individuals, and there is not enough evidence to support the clinical use of antibody examination. This study evaluates the diagnostic value of serologic tests for diagnosing COVID-19.
Materials and Methods: 32 patients for whom serologic testing was performed within 7 to 21 days from symptom onset and whether they were diagnosed with COVID-19 by both PCR and lung HRCT as gold standard tests at the same time, were included in the study.
Results: Serologic tests (IgM / IgG) compared to PCR and lung HRCT scan to diagnose COVID-19, were 89.3% specific and 59.6% sensitive. Positive predictive value (PPV) was 95% and negative predictive value (NPV) was 37%. The diagnostic accuracy index of the serologic test was 0.745 (CI 0.651-0.838) (p-value <0.001).
Conclusion: Serologic testing can be a complementary alternative for SARA-CoV-2 nucleic acid RT-PCR, although it cannot replace it completely. IgG/IgM combo test kits and RT-PCR together can give more insight into the diagnosis of SARS-CoV-2.

1. Shen B, Zheng Y, Zhang X, Zhang W, Wang D, Jin J, et al. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG. Am J Transl Res 2020; 12: 1348-1354.
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382: 727-733.
3. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9: 221-236.
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
5. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis 2020; 71: 2027-2034.
6. World Health Organization. Clinical management of COVID-19: Living guideline, 18 August 2023.
https://files.magicapp.org/guideline/be40cb35-5101-4307-8ae6-06b5694bf575/published_guideline_6915-7_0.pdf
7. Liu Y, Liu YP, Diao B, Ding JY, Yuan MX, Ren FF, et al. Diagnostic indexes of a rapid immunoglobulin G/immunoglobulin M combined antibody test for severe acute respiratory syndrome coronavirus 2. Chin Med J (Engl) 2020; 134: 475-477.
8. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25: 2000045.
9. Yang F, Feng S, Li Y, He Y, Jin X, Wang X, et al. Development of immunochromatographic test strips for rapid, quantitative detection of H9AIV antibodies. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1095: 59-64.
10. Pan American Health Organization (2022). Case definitions for COVID-19 surveillance. https://www.paho.org/en/case-definitions-covid-19-surveillance
11. Parikh R, Mathai A, Parikh S, Chandra Sekhar G, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol 2008; 56: 45-50.
12. Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for medical diagnostic test evaluation. Caspian J Intern Med 2013; 4: 627-635.
13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected Pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069.
14. Gutiérrez-Cobos A, Gómez de Frutos S, Domingo García D, Navarro Lara E, Yarci Carrión A, Fontán García-Rodrigo L, et al. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies. Eur J Clin Microbiol Infect Dis 2021; 40: 955-961.
15. Kundu D, Gautam P, Dayanand D, Gunasekaran K, Manesh A, Sebastian M, et al. The role and diagnostic accuracy of serology for COVID-19. BMC Infect Dis 2022; 22: 390.
16. Jarrom D, Elston L, Washington J, Prettyjohns M, Cann K, Myles S, et al. Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review. BMJ Evid Based Med 2022; 27: 33-45.
17. Fu H, Sun L, Zhu J. Detection of antibody versus antigen, optimal option of different serological assays based tests for COVID-19 diagnosis: A Meta-Analysis. Iran J Public Health 2023; 52: 23-36.
Files
IssueVol 16 No 4 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v16i4.16310
Keywords
COVID-19; SARS-CoV-2 virus; COVID-19 serological testing; COVID-19 reverse transcription polymerase chain reaction; Computed tomography scan; X-ray
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Shirani K, Hajihashemi M, Mortazavi A, Assadi A, Baradaran A, Ataei B, Badei H. Diagnostic value of antibody testing in comparison with lung scan and PCR in patients suspected of having COVID-19. Iran J Microbiol. 2024;16(4):509-514.